Randomized, open label, controlled trial of integrated traditional Chinese and Western medicine in the treatment of interventional treated acute coronary syndrome patients

INTERVENTION: Control group:conventional drug treatment according to guide;Integrated TCM and WM group:conventional therapy plus Xinyue capsule plus Xiongshao capsule; CONDITION: Acute coronary syndrome PRIMARY OUTCOME: Mortality;Cardiovascular event rate; SECONDARY OUTCOME: laboratory outcome; INCLUSION CRITERIA: 1. According to the diagnosis standard of UA or AMI(including patients with ST segment run up and non‐ ST segment run up); 2. males and females with age 18 to 75(including 18 and 75); 3. Patients who achieved success in the treatment of coronary heart disease by interventional therapy; 4. patients who willing to be followed‐up.